BioNTech SE American Depositary Share Share Price Today, Forecast Target, Chat & Where To Buy [BNTX]

Home > Share Prices > BioNTech SE American Depositary Share share price (BNTX)

Today's BioNTech SE American Depositary Share share price is 105.65 (as of 12:23 09-Oct-2025) which is a change of 0.63 or 0.59% from the last closing price of 105.65 with 212,553 shares traded giving BioNTech SE American Depositary Share a market capitalisation of 25,339,716,918. The most recent daily high has been 106.92 and daily low 105.23. The BioNTech SE American Depositary Share share price 52 week high has been 129.27 and the 52 week low 81.2. Based on the most recent BioNTech SE American Depositary Share share price opening of 105.65, the current BioNTech SE American Depositary Share EPS (earnings per share) are -3.13 and the PE (price earnings ratio) is 153.23.

Featured Brokers For Buying BioNTech SE American Depositary Share Shares

It currently costs 105.65 to buy one share in BioNTech SE American Depositary Share (as of 12:23 09-Oct-2025) which is a change of 0.63 or 0.59% from the last closing price of 106.28. To buy shares in BioNTech SE American Depositary Share you will need a stock trading platform like Interactive Brokers, IG or AJ Bell.

You can buy these shares in either a general investment account, stocks & shares ISA or SIPP for your pension with one of the brokers below.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is BioNTech SE American Depositary Share A Good Investment?

The below BioNTech SE American Depositary Share share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.

Tell us what you think:

Scroll to Top